AHL
EDIT icon

Abel Hall LLC’s Editas Medicine EDIT Stock Holding History

Abel Hall LLC’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.6K Buy
14,703
+260
+2% +$760 0.01% 899
2026
Q1 		$35.7K Buy
+14,443
New +$30.6K 0.01% 768

Other funds holding EDIT

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWM
Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Abel Hall LLC's EDIT Position: Q2 2026 in Review

Abel Hall LLC increased its Editas Medicine (EDIT) stake by 1.8% in Q2 2026, buying an estimated $760 and bringing the position to 14,703 shares worth $47.6K. The position accounts for 0.01% of the portfolio, ranked #899.

Abel Hall LLC first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Abel Hall LLC held 14,703 shares of Editas Medicine worth $47.6K as of Q2 2026.
  • Abel Hall LLC bought 260 Editas Medicine shares in Q2 2026, an estimated $760.
  • Editas Medicine made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #899 holding.
  • Abel Hall LLC first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
  • 49 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.